| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| mechanism of action of nivolumab | 0.37 | 0.9 | 4324 | 38 |
| ipilimumab and nivolumab mechanism of action | 1.62 | 0.7 | 3506 | 2 |
| nivolumab mode of action | 0.6 | 0.6 | 8585 | 33 |
| nivolumab for renal cell mechanism of action | 1.95 | 1 | 106 | 100 |
| nivolumab duration of action | 1.61 | 0.4 | 7875 | 16 |
| how does nivolumab work | 0.87 | 0.9 | 7074 | 20 |
| ianalumab mechanism of action | 0.55 | 0.6 | 5391 | 1 |
| nivolumab side effects management | 1.56 | 0.1 | 9182 | 36 |
| what is in nivolumab | 1.57 | 0.6 | 9414 | 2 |
| nivolumab mecanismo de accion | 0.26 | 0.8 | 9218 | 18 |
| injection nivolumab 1 mg | 1.1 | 0.3 | 174 | 65 |
| what is nivolumab therapy | 1.53 | 0.3 | 6764 | 8 |
| nivolumab used to treat | 1.71 | 0.3 | 4136 | 9 |
| what does nivolumab target | 0.82 | 0.6 | 2986 | 91 |
| what is nivolumab drug | 1.7 | 0.3 | 3632 | 57 |
| how is nivolumab administered | 0.16 | 0.9 | 2962 | 66 |
| what is nivolumab infusion | 1.95 | 0.2 | 8798 | 77 |
| fiche info patient nivolumab | 1.99 | 0.7 | 3269 | 89 |
| nivolumab combination therapy in advanced | 1.36 | 0.1 | 7888 | 95 |
| nivolumab immune related adverse events | 0.83 | 0.7 | 9583 | 8 |
